Accord Logo

Intended for UK patients and members of the public

PIL- Bivalirudin 250 mg Powder for Concentrate for solution for injection or infusion: Change history

Back to products
  • View Patient Information Leaflet (PIL- Bivalirudin 250 mg Powder for Concentrate for solution for injection or infusion)

    Last updated on this site: 09 Sep 2026

    Expanded Renewal: updates to SPC sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 6.5, 6.6, 9 and 10, PIL and labelling.

    MHRA approval date: 07/09/2026

    PIL sections updated: Heading, index, 1, 2, 3, 4, 5, 6 and HCP section

    View change history

    • Changes: (Updated: 09 Sep 2026)

      Expanded Renewal: updates to SPC sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 6.5, 6.6, 9 and 10, PIL and labelling.

      MHRA approval date: 07/09/2026

      PIL sections updated: Heading, index, 1, 2, 3, 4, 5, 6 and HCP section

    • Changes: (Updated: 20 Sep 2022)

      Initial upload

    Back to Top

    View product information as a: